Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Construction in Progress (2020 - 2021)

Rani Therapeutics Holdings (RANI) has 2 years of Construction in Progress data on record, last reported at $3.5 million in Q4 2021.

  • For Q4 2021, Construction in Progress changed 0.0% year-over-year to $3.5 million; the TTM value through Dec 2021 reached $3.5 million, changed 0.0%, while the annual FY2021 figure was $3.5 million, 0.0% changed from the prior year.
  • Construction in Progress reached $3.5 million in Q4 2021 per RANI's latest filing, roughly flat from $3.5 million in the prior quarter.
  • Across five years, Construction in Progress topped out at $3.5 million in Q4 2020 and bottomed at $3.5 million in Q4 2020.